SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Webull Corp. engages in the provision of financial services. It offers trading, wealth management product distribution, market data and information, user community, and investor education. The company was founded by An Quan Wang in 2016 and is headquartered in St. Petersburg, FL.

Webull Corp. - Ordinary Shares - Class A

Webull Corp

Webull is currently drawing heavy retail interest as traders bet on a potential post-earnings breakout, with massive call volume and discussions centered on the upcoming results acting as a catalyst for a possible price squeeze. Despite the persistent frustration over the stock's long-term stagnation in the seven-dollar range, the community remains divided between those viewing current volatility as a manipulation-driven stop-loss raid and those aggressively loading positions in anticipation of a significant move.

Adobe, Inc. is a global technology company, which engages in the provision of digital marketing and media solutions. It operates through the following segments: Digital Media, Digital Experience, and Publishing and Advertising. The Digital Media segment offers products and services that enable individuals, teams, businesses, and enterprises to create, publish, and promote content anywhere and accelerate productivity by transforming view, share, engage with and collaborate on documents and creative content. The Digital Experience segment focuses on integrated platform and set of products, services, and solutions that enable businesses to create, manage, execute, measure, monetize, and optimize customer experiences that span from analytics to commerce. The Publishing and Advertising segment includes legacy products and services that address diverse market opportunities, including eLearning solutions, technical document publishing, web conferencing, document and forms platform, web app development, high-end printing, and Adobe Advertising offerings. The company was founded by Charles M. Geschke and John E. Warnock in December 1982 and is headquartered in San Jose, CA.

Adobe Inc

Adobe is facing significant volatility as investors debate whether AI adoption will act as a major growth catalyst or a competitive threat to its core business. The community remains deeply divided, with many traders focused on technical support levels and massive buyback programs, while others remain skeptical about the software sector's resilience against the rapid advancement of generative AI tools.

D-Wave Quantum, Inc. engages in the development and delivery of quantum computing systems, software, and services. It provides customers with access to the company’s quantum computing systems via the cloud in the form of quantum computing as a service. It offers professional services such as customer assistance in identifying and implementing quantum-computing applications. The company was founded on January 25, 2022 and is headquartered in Palo Alto, CA.

D-Wave Quantum Inc

D-Wave Quantum is trending as investors react to a significant government funding initiative, where the company signed a letter of intent for a multimillion-dollar investment in exchange for equity. While the community remains sharply divided, with some highlighting record-breaking bookings and others expressing skepticism over profitability and potential share dilution, the stock continues to see high volume and intense volatility as traders debate its long-term viability in the quantum sector.

Arm Holdings Plc engages in the licensing, marketing, research, and development of microprocessors, systems IP, graphics processing units, physical IP and associated systems IP, software, and tools. It operates through the following geographical segments: United Kingdom, United States, and Other Countries. The company was founded on November 12, 1990 and is headquartered in Cambridge, the United Kingdom.

Arm Holdings plc. - ADR

Arm Holdings Plc.

Arm Holdings is currently experiencing high volatility driven by extreme FOMO and investor speculation, with the community sharply divided between those betting on the company's long-term potential in AI and data center architectures and those warning that the recent price surge is a manipulated bubble disconnected from fundamentals. Market participants are intensely debating the impact of SoftBank's heavy float ownership, recent insider selling, and analyst skepticism, while traders actively seek to capitalize on or hedge against the stock's parabolic momentum.

Rigetti Computing, Inc. provides full-stack quantum computing services. It serves global enterprise, government, and research clients through its Rigetti Quantum Cloud Services platform. The company was founded by Chad Rigetti in 2013 and is headquartered in Berkeley, CA.

Rigetti Computing Inc

Rigetti Computing is capturing significant investor attention following a major government commitment of $100 million in funding to accelerate its quantum R&D, a move widely viewed as a signal of long-term strategic importance. The community is actively debating the stock's valuation relative to its revenue, with some bullish participants pointing to sovereign-backed validation as a catalyst for future growth while skeptics express caution regarding dilution and the long timeline to commercial scalability.

Micware Co. Ltd. engages in software development services and innovative IT solutions mainly focused on the automotive and mobility sectors. It operates through the following segments: Software Defined Vehicles (SDV), Location-Based Services (LBS), and Others. The SDV segment relates to the development and sale of software systems designed for SDV, including IVI system software and other mobility-enhancing software products, conducted by its Japanese subsidiaries. The LBS segment covers the development and licensing of in-vehicle navigation software systems, and other geographic data-based services for business-to-business customers, mainly serving end users. The Other segment comprises software development services conducted by overseas subsidiaries designed for SDV, and business-to-consumer mobile app services unrelated to in-vehicle navigation. The company was founded by Kenji Narishima in March 2003 and is headquartered in Kobe, Japan.

Micware Co. Ltd. - ADR

Micware Co. Ltd. (MWC) is experiencing intense volatility and trading activity as investors react to its recent IPO status and strategic partnerships with major automotive manufacturers like Toyota and Honda. The community is sharply divided, with bulls anticipating a short squeeze or significant upside potential, while bears frequently label the aggressive price swings as a classic pump-and-dump scheme.

Walmart, Inc. engages in the retail and wholesale business. The company offers an assortment of merchandise and services at everyday low prices. It operates through the following business segments: Walmart U.S., Walmart International, and Sam's Club. The Walmart U.S. segment operates as a mass merchandiser of consumer products, operating under the Walmart and Walmart Neighborhood Market brands, including walmart.com. The Walmart International segment includes operations of wholly-owned subsidiaries in Canada, Chile, China, and Africa, and majority-owned subsidiaries in India, as well as Mexico and Central America. The Sam's Club segment manages membership-only warehouse clubs and operates samsclub.com. The company was founded by Samuel Moore Walton and James Lawrence Walton on July 2, 1962 and is headquartered in Bentonville, AR.

Walmart Inc

Walmart is currently in focus as investors balance its reputation as a defensive, high-valuation retail leader against potential margin pressures from persistent inflation and broader consumer spending headwinds. The community is actively debating the stock's elevated P/E ratio, with bullish traders highlighting its strategic e-commerce and advertising growth, while bears express concern over the company's sensitivity to rising fuel costs and shifting discretionary demand.

Redwire Corp. manufactures and supplies space equipment. It offers critical space solutions and reliability components for the next generation space economy with IP for solar power generation and in-space 3D printing and manufacturing. It assists its customers in solving challenges of future space missions. The company was founded in 2020 and is headquartered in Jacksonville, FL.

Redwire Corporation

Redwire Corp

Redwire Corp is seeing significant volatility and high retail engagement as investors position themselves ahead of the SpaceX IPO, viewing the stock as an undervalued infrastructure play for the space economy. Community sentiment remains bullish, with traders actively discussing recent contract awards and dismissing short-term dips as institutional manipulation or shakeouts of weaker hands.

Workday, Inc. engages in the provision of development of enterprise cloud applications for finance and human resources. It delivers financial management, human capital management and analytics applications designed for companies, educational institutions, and government agencies. The company was founded by David A. Duffield and Aneel Bhusri in 2005 and is headquartered in Pleasanton, CA.

Workday Inc - Ordinary Shares - Class A

Workday Inc

Workday is trending following a double earnings beat that topped revenue and EPS estimates, sparking a volatile market reaction as investors weigh the results against concerns about software-as-a-service (SaaS) demand and AI-driven disruption. The community is actively debating whether the stock is undervalued after a significant decline or if the sector remains fundamentally pressured by artificial intelligence shifting corporate spending patterns.

Infleqtion, Inc. engages in delivering neutral atom solutions for quantum computing, networking, sensing, and security. Its products are categorized into computing, sensing, and cores. The company was founded on February 7, 2007, and is headquartered in Louisville, CO.

Infleqtion Inc. - Ordinary Shares - Class A

Infleqtion Inc.

Infleqtion is seeing heightened market activity following a major government announcement that it will receive $100 million in federal funding alongside equity participation as part of a $2 billion strategic investment across the quantum sector. Investors are actively discussing the firm's pivot to a state-backed infrastructure role, with sentiment split between excitement over this long-term technological validation and intense debate regarding potential share dilution and price support levels.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Compass Therapeutics, Inc. - CMPX

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Compass Therapeutics, Inc. - CMPX INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of...

Canaccord Genuity Group Lowers Compass Therapeutics (NASDAQ:CMPX) Price Target to $7.00

Canaccord Genuity Group dropped their price objective on shares of Compass Therapeutics from $13.00 to $7.00 and set a "buy" rating for the company in a report on Tuesday...

Citizens Jmp Reiterates Market Outperform Rating for Compass Therapeutics (NASDAQ:CMPX)

Citizens Jmp restated a "market outperform" rating and issued a $10.00 price target on shares of Compass Therapeutics in a research note on Tuesday...

Compass Therapeutics (NASDAQ:CMPX) Hits New 12-Month Low  - What's Next?

Compass Therapeutics (NASDAQ:CMPX) Reaches New 52-Week Low - Here's Why...

Compass Therapeutics Touts Stunning PFS Win in COMPANION-002 as Crossover Muddy OS Data

Compass Therapeutics (NASDAQ:CMPX) executives highlighted what CEO and Vice Chair Dr. Thomas Schuetz called absolutely stunning progression-free survival results from the company's phase II/III...

Compass Therapeutics Drops Sharply As Trial Crossover Complicates Survival Data In Bile Duct Cancer Patients

Compass Therapeutics says tovecimig misses overall survival endpoint in biliary tract cancer study, but data shows progression-free survival and response rates.read more...

Compass Therapeutics' (CMPX) "Buy" Rating Reaffirmed at D. Boral Capital

D. Boral Capital restated a "buy" rating and issued a $30.00 price objective on shares of Compass Therapeutics in a report on Monday...

<ul class="summary-bullets"><li>The trial is testing Tovecimig in combination with Paclitaxel in patients with a rare disease affecting the bile ducts or gallbladder, often detected at an advanced stage.</li><li>The company expects to report progression-free survival and overall survival results.</li><li>Earlier data showed that the combination delivered an overall response rate of 17.1%, compared with 5.3% for Paclitaxel alone.</li></ul>Compass Therapeutics (CMPX), a biotech company focused on antibody-driven cancer treatments, drew strong retail interest on Monday as investors looked ahead to the upcoming topline data on secondary endpoints from its Phase 2/3 COMPANION-002 trial for advanced biliary tract cancerThe trial is testing Tovecimig in combination with Paclitaxel in patients with biliary tract cancer, a rare disease that affects the bile ducts or gallbladder, and is often detected at a late stage.At the time of writing, <a href="https://stocktwits.com/symbol/CMPX">CMPX shares</a> were down around 11% in pre-market trading. The stock has ended lower in five of the last six sessions.<h2 class="st-heading-2">Compass To Launch Separate Trial For Tovecimig</h2>The company expects to report progression-free survival (PFS) and overall survival (OS) results, marking a key milestone for the program. Tovecimig, a bispecific antibody, is being tested in combination with Paclitaxel in patients with advanced biliary tract cancer who have already received prior chemotherapy.Earlier data showed that the combination delivered an overall response rate of 17.1%, compared with 5.3% for Paclitaxel alone, a statistically significant improvement. The study also demonstrated lower disease progression rates in the combination arm.The randomized trial enrolled 168 patients, and safety findings to date are consistent with prior studies. Meanwhile, Compass also plans to launch a separate Phase 2 trial in mid-2026 to evaluate Tovecimig across a broader set of Delta-like ligand 4 (DLL4)-positive tumors. DLL4 is a protein that regulates blood vessel growth.<h2 class="st-heading-2">How Did Retail Traders React?</h2>Despite the pre-market slide, retail sentiment on Stocktwits remained ‘extremely bullish’ over the past 24 hours, amid ‘extremely high’ message volumes.One user said that if the upcoming results beat existing standards, it could meaningfully improve treatment for advanced patients.<stembedurl>https://stocktwits.com/4Reel/message/651471837</stembedurl>The stock is down more than 1% so far in 2026.For updates and corrections, email newsroom[at]stocktwits[dot]com.

S&P 500 Index trades listlessly ahead of Nvidia earnings. 

This Small-Cap Biotech Is Gearing Up For A Make-Or-Break Cancer Drug Data Drop

The biotech firm is set to report topline data on secondary endpoints from its Phase 2/3 trial for advanced biliary tract cancer on Monday.

CMPX Stock Has Retail Buzzing Ahead Of High-Stakes Cancer Drug Trial Update

Equity

M&T Bank Corp Makes New $4.10 Million Investment in Compass Therapeutics, Inc. $CMPX

M&T Bank Corp bought a new position in Compass Therapeutics, Inc. (NASDAQ:CMPX - Free Report) in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor bought 764,229 shares of the company's stoc...

Compass Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the development of proprietary antibody therapeutics. Its platform includes common light chain-focused antibody discovery, human display for antibody tuning, stitchmabs, and highly modular and manufacturable bispecific candidates. The company was founded by Thomas J. Schuetz in 2014 and is headquartered in Boston, MA.

Fiscal Period	Estimated	Reported	Surprise	Result
Q2 '26	-$0.11	--	--	N/A
Q1 '26	-$0.10	-$0.10	-1.92%	MISSED
Q4 '25	-$0.09	-$0.09	1.21%	BEAT
Q3 '25	-$0.14	-$0.08	42.55%	BEAT
Q2 '25	-$0.12	-$0.14	-12.90%	MISSED

CMPX
Compass Therapeutics Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest Earnings Results: Q1 '26

Historical Earnings

Latest CMPX News

CMPXCompass Therapeutics Inc